Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sales of veterinary biological products, veterinary drug preparations, functional additives, and veterinary raw materials in China. The company provides vaccines and drugs for poultry, swine, and other animals; pet products comprising pet rabies inactivated vaccine, recombinant canine-a interferon, inhalation anesthetics isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate for injection for prevention and treatment of pet bacterial diseases, heart disease drugs for dogs and cats, napril chewable tablets and other products; and waterfowl products, including duck tempusu live/inactivated vaccine, gosling plague refined egg yolk antibody, duck infectious serositis inactivated vaccine, duck viral hepatitis refined egg yolk antibody, duck plague live vaccine, florfenicol soluble powder, kanamycin injection, etc. It also offers antifungal products, such as natural plant extracts, immune polysaccharides, clostridium butyricum, lactobacillus plantarum, antibacterial peptides, enzyme preparations, acidulants, etc; disinfection and cleaning products, consisting of potassium hydrogen persulfate composite powder, benzyl trimethyl ammonium chloride solution, deca methyl ammonium bromide solution, sodium dichloroisocyanurate, iodine glycerin solution, etc.; and APIs comprising tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, gamimycin, etc. The company was founded in 1998 and is based in Tianjin, China.
Ringpu Bio Technology was founded in 2011 in Tianjin, China. Initially, the company focused on providing research and development services to pharmaceutical and biotechnology companies. In 2014, the company began marketing its own proprietary products, with a focus on health-related products. Since then, the company has established relationships with some of the world's leading corporations in the healthcare industry, including Merck, Novo Nordisk, and AstraZeneca.
Ringpu Bio Technology has won multiple awards since its founding, including the Innovation Award at the International Biotechnology Congress and the Excellence in R & D Award at the International Bio-Technology Forum . In 2017, the company was recognized as one of the top 10 emerging healthcare companies in China by the Chinese Healthcare Industry Think Tank.
